LITTLE ROCK, Ark. — Two pharmaceutical companies asked a federal judge Thursday to prevent Arkansas from using their drugs to execute seven inmates by the end of the month, saying they object to their products being used for capital punishment.
Fresenius Kabi USA and West-Ward Pharmaceuticals Corp. were granted permission to file a friend of the court brief in a lawsuit by the inmates aimed at halting the unprecedented execution schedule, set to begin Monday with the lethal injection of two condemned killers.
Fresenius Kabi said it appeared that it had manufactured the potassium chloride the state plans to use, while West-Ward had previously been identified by the Associated Press as the likely manufacturer of the state’s supply of midazolam.
“The use of the medicines in lethal injections runs counter to the manufacturers’ mission to save and enhance patients’ lives, and carries with it not only a public-health risk, but also reputational, fiscal, and legal risks,” the companies said in a filing with the court.
Arkansas prison officials announced last month they had obtained a new supply of potassium chloride, clearing the way for the executions to begin. The executions are scheduled to occur before Arkansas’ supply of midazolam, a sedative used in flawed executions in other states, expires at the end of April.
A 2015 state law keeps the source of Arkansas’ three lethal injection drugs secret. The Department of Correction, Governor Asa Hutchinson’s office and the attorney general’s office declined to comment on Thursday’s filing by the companies.
“We have made repeated as of yet unsuccessful representations in writing and in person to the governor’s office, office of the attorney general and the Department of Corrections to confirm if they are in possession of our product which they intend to use in lethal injections, and if so to return it to us,” Brooke Clarke, a spokeswoman for Hikma, West-Ward’s parent company, said in a statement.
Fresenius said it has made similar overtures to Hutchinson and state officials, but hasn’t received any response.
Both companies said they’ve put strict controls on their supplies to ensure the drugs aren’t used in capital punishment. Fresenius said its information indicated no sales of its potassium chloride directly or through its authorized distributors to the state’s prison system.
“So we can only conclude Arkansas may have acquired this product from an unauthorized seller,” Matt Kuhn, a spokesman for the company, said in a statement. “Pharmaceuticals obtained in this manner are at risk of adulteration or chemical change due to improper handling such as failure to maintain proper temperature levels during storage and transport.”
US District Court Judge Kristine Baker is expected to rule Friday in the inmates’ request to halt the executions. The inmates are challenging the compressed execution timetable, as well as the use of midazolam.
Arkansas has not executed an inmate since 2005 because of drug shortages and legal challenges. If carried out, the executions would mark the most inmates put to death by a state in such a short period in modern history.
— Andrew DeMillo